Correspondence
Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure
Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente
a School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia
b School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya, Selangor, Malaysia
c School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom
d School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia
Read
972
Timeswas read the article
38
Total PDF
934
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 June | 1 | 0 | 1 |
| 2023 May | 48 | 6 | 54 |
| 2023 April | 29 | 0 | 29 |
| 2023 March | 32 | 5 | 37 |
| 2023 February | 29 | 0 | 29 |
| 2023 January | 36 | 0 | 36 |
| 2022 December | 43 | 0 | 43 |
| 2022 November | 37 | 0 | 37 |
| 2022 October | 48 | 2 | 50 |
| 2022 September | 63 | 2 | 65 |
| 2022 August | 82 | 2 | 84 |
| 2022 July | 72 | 3 | 75 |
| 2022 June | 63 | 0 | 63 |
| 2022 May | 153 | 6 | 159 |
| 2022 April | 30 | 4 | 34 |
| 2022 March | 54 | 3 | 57 |
| 2022 February | 85 | 3 | 88 |
| 2022 January | 29 | 2 | 31 |
Show all
